Navigation Links
Sysmex America Awarded MedAssets Supply Chain Systems Hematology Contract Extension
Date:10/24/2007

Technical Merit and Pricing Key Factors

MUNDELEIN, Ill., Oct. 24 /PRNewswire/ -- Sysmex America, Inc. today announced that the company has been awarded a hematology contract extension by group purchasing organization MedAssets Supply Chain Systems. The extension agreement provides MedAssets' customers access to Sysmex hematology analyzers, reagents, consumables and services effective October 1, 2007, said John Kershaw, President, Sysmex America, Inc. Training and technical support for the organization's members will be provided through the company's U.S. headquarters in Mundelein. This contract extends the original contract between the companies that originated in April 2004.

"MedAssets Supply Chain Systems awards contracts to companies based on extensive criteria including product quality and customer service. Sysmex America's proven performance with our customers during the past three years, including an award in MedAssets' first ever Group Buy Initiative for hematology, merits the extension of the company's contract. Sysmex's offer of exceptional value through this program underscores their commitment to our customer base," said Mary Ellen Kimmeth, Vice President, Laboratory & Capital Equipment Services, MedAssets Supply Chain Systems.

"We at Sysmex America are pleased that MedAssets and its customers will retain its working relationship with our company. Their access to reliable and proven Sysmex hematology analyzers will serve them well as they seek greater efficiency and effectiveness in an increasingly challenging healthcare environment," said Kershaw.

Sysmex hematology products included in the MedAssets contract agreement range from the pocH-100i(TM) and the KX-21N(TM) for small laboratories to the fully automated XE-Alpha N(TM) and HST-N(TM) Integrated Hematology Systems with automated slide preparation capabilities. Also included are the Sysmex(R) XE-Series Automated Hematology Analyzers, the Sysmex XT-Series A
'/>"/>

SOURCE Sysmex America, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. A disgusting video: U.S. companies sell out Americans
2. Northwestern Mutual, American Family make Computerworlds best IT workplaces
3. Brazilian bio-industry should impress American investors
4. DHC 2007: Without fuller IT adoption, health costs might drain Americas wealth
5. Silver linings in the cloud: Americas dearth of STEM students
6. CIO Leadership Series: Byrne Chapman, American Family Insurance
7. Metavante fires 180 North American workers
8. 300 millionth American no cause for eco-alarm
9. American Idol spurs music software
10. Healthcare software addresses "90 million" misclassified Americans
11. Technology and the "American" dream
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...all/ -- Delcath Systems, Inc. (Nasdaq: DCTH ) to...s stepped down from his position as a director of ...s advised the Company that his decision to leave t...ents to new leadership positions. , , (Logo...Y46990LOGO ) , , Dr. Harold Koplewicz, Chai...
(Date:12/4/2008)...iosystems, part of Life Technologies Corporation (...e research and discovery solutions, today announce...analysis, the SOLiD™ System, has been named ...y The Scientist, a leading scientific publication ...e announcement of the first-ever Life Science Inno...
(Date:12/3/2008)...-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV ),a glob...e appointment of John,L. Miclot to its Board of D...t is currently the president and chief executive o...e provider of various home care products,for chro... and respiratory,disorders. Prior to joining CCS...
(Date:12/3/2008)... CeloNova BioSciences, Inc., announced,today that...alizing the,CATANIA(TM) Coronary Stent System wit...as not had any stent thrombosis in clinical studie...oughout Europe and now some Middle,Eastern countr...Concurrently,CeloNova notes that it has received...
Breaking Biology Technology:Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of Directors 2 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 2 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 3 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 4 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 5ev3 Inc. Appoints John L. Miclot to Board of Directors 2CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 2CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 3
...lular structure discovered 125 years ago and dismi...been found to play a key role in the process of cy...nt and important of all biological phenomena. , ,T...eins harbored within this structure - which are ne...ientists led by a University of Wisconsin-Madison ...
... secret Wisconsin fares poorly when it comes to at...ngs, Wisconsin scores in the bottom five in gettin... send to Uncle Sam. In bringing home the bacon, Wi...eptions are those federal programs where Wisconsin...-tech companies, compete on merit rather than the ...
...o of a three-part series focusing on the past, pre...itiatives and serves as a follow up to WTNs inter...rt 3 , , WTN: During the next six to 12 months, w...o see passed or enacted? , , Cory Nettles: I had...here we talked about the Dept. of Commerces activi...
... of the people who helped North Carolina and Los A... surprisingly public communities of angel investor... the Entrepreneurs Conference in Milwaukee . , ,T...ou have to be careful with that word, said Monica ...l Development , based in North Carolinas Research ...
Other Biology Technology:UW-Madison scientists find a key to cell division 2UW-Madison scientists find a key to cell division 3Heres one federal program where Wisconsin has gained some hard-earned ground 2Heres one federal program where Wisconsin has gained some hard-earned ground 3WTN exclusive interview with Commerce Secretary Cory Nettles (part 2) 2WTN exclusive interview with Commerce Secretary Cory Nettles (part 2) 3WTN exclusive interview with Commerce Secretary Cory Nettles (part 2) 4WTN exclusive interview with Commerce Secretary Cory Nettles (part 2) 5Experts share advice for Wisconsin entrepreneur programs 2Experts share advice for Wisconsin entrepreneur programs 3Experts share advice for Wisconsin entrepreneur programs 4
(Date:12/3/2008)... to forget that a dam and pond stood for 43 years ... Farm Research Station in southwestern Wisconsin. ... plants, both native and weedy, now carpet the flo... of the dam remain, and by digging into the soils ...thing them. Writing in a special issue (December) ...
(Date:12/3/2008)...help improve a person,s golf game, stream salamand...ocal country club in the near future, following a ...ore than 17,000 golf courses in the United States,...used for playing," said Ray Semlitsch, Curators, P...Science. "These managed green spaces aren,t surrog...
(Date:12/3/2008)...individuals can respond just as well to placebos, ...hand, it is difficult to explain why only certain ...chers from Uppsala University and Gothenburg Unive... the placebo effect and a mechanism in the brain t..., The study, published in Journal of Neuroscienc...
(Date:12/3/2008)...International Society for Stem Cell Research (ISSC...of stem cell researchers, released new guidelines ...ive stem cell therapies for patients. A Commentary...inical Translation of Stem Cells will be published... Cell , the official affiliated journal of the ISS...
Breaking Biology News(10 mins):Researchers examine role of soil patterns in dam restoration 2Researchers examine role of soil patterns in dam restoration 3Golf course: Playing fields, wildlife sanctuaries or both 2Genes determine whether sugar pills work 2The International Society for Stem Cell Research releases new guidelines 2The International Society for Stem Cell Research releases new guidelines 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2881 1Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2881 2Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2881 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2881 4Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2881 5Kmart Pharmacy Awards Its Transaction Processing Business to eRx Network 25676 1Kmart Pharmacy Awards Its Transaction Processing Business to eRx Network 25676 2Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS ETR1 in Non Small Cell Lung Cancer 2879 1Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS ETR1 in Non Small Cell Lung Cancer 2879 2Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS ETR1 in Non Small Cell Lung Cancer 2879 3Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS ETR1 in Non Small Cell Lung Cancer 2879 4Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS ETR1 in Non Small Cell Lung Cancer 2879 5FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals Lead Product Candidate OGX 011 7283 1FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals Lead Product Candidate OGX 011 7283 2FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals Lead Product Candidate OGX 011 7283 3FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals Lead Product Candidate OGX 011 7283 4
...With the introduction of just four factors, resear...ls taken from mouse embryos or adult mice to behav...ted their findings in an immediate early publicati..., The cells--which the researchers designate "indu...sical, growth, and genetic characteristics typical...
...An enzyme that helps neurons rid themselves of exc...ain function, according to a new report in the Aug...by Cell Press. What,s more, by increasing brain le...ms, the researchers found they could reverse lapse...ease. , Treatments that elevate the protein, know...
...Bacteria and fungi, some with the potential to cau...eir way from Africa to the Americas by hitchhiking... in the Sahara, according to research presented to...ociety for Microbiology in Orlando, Florida. , "T...al and transport of microorganisms from North Afri...
...Researchers have identified the genes in gum-disea...uman arterial cells, offering one possible explana...e and heart disease. Scientists from the Universi... today at the 106th General Meeting of the America... "Aside from lifestyle and genetic factors, there ...
Other Biology News:With few factors, adult cells take on character of embryonic stem cells 2Brain enzyme treatment relieves memory lapse in Alzheimer's mice 2Brain enzyme treatment relieves memory lapse in Alzheimer's mice 3Microbes hitchhike across Atlantic on desert dust 2